Phytochemical Assays of Commercial Botanical Dietary Supplements

The growing popularity of botanical dietary supplements (BDS) has been accompanied by concerns regarding the quality of commercial products. Health care providers, in particular, have an interest in knowing about product quality, in view of the issues related to herb-drug interactions and potential...

Full description

Bibliographic Details
Main Authors: Robert Krochmal, Mary Hardy, Susan Bowerman, Qing-Yi Lu, H-J Wang, RM Elashoff, David Heber
Format: Article
Language:English
Published: Hindawi Limited 2004-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1093/ecam/neh040
id doaj-8f10ab0391f947b98a17a11684b1edca
record_format Article
spelling doaj-8f10ab0391f947b98a17a11684b1edca2020-11-24T23:42:24ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882004-01-011330531310.1093/ecam/neh040Phytochemical Assays of Commercial Botanical Dietary SupplementsRobert Krochmal0Mary Hardy1Susan Bowerman2Qing-Yi Lu3H-J Wang4RM Elashoff5David Heber6UCLA Center for Human Nutrition, 900 Veteran Avenue, Los Angeles, CA 90095, USAUCLA Center for Human Nutrition, 900 Veteran Avenue, Los Angeles, CA 90095, USAUCLA Center for Human Nutrition, 900 Veteran Avenue, Los Angeles, CA 90095, USAUCLA Center for Human Nutrition, 900 Veteran Avenue, Los Angeles, CA 90095, USAUCLA Center for Human Nutrition, 900 Veteran Avenue, Los Angeles, CA 90095, USAUCLA Center for Human Nutrition, 900 Veteran Avenue, Los Angeles, CA 90095, USAUCLA Center for Human Nutrition, 900 Veteran Avenue, Los Angeles, CA 90095, USAThe growing popularity of botanical dietary supplements (BDS) has been accompanied by concerns regarding the quality of commercial products. Health care providers, in particular, have an interest in knowing about product quality, in view of the issues related to herb-drug interactions and potential side effects. This study assessed whether commercial formulations of saw palmetto, kava kava, echinacea, ginseng and St. John's wort had consistent labeling and whether quantities of marker compounds agreed with the amounts stated on the label. We purchased six bottles each of two lots of supplements from nine manufacturers and analyzed the contents using established commercial methodologies at an independent laboratory. Product labels were found to vary in the information provided, such as serving recommendations and information about the herb itself (species, part of the plant, marker compound, etc.) With regard to marker compound content, little variability was observed between different lots of the same brand, while the content did vary widely between brands (e.g. total phenolic compounds in Echinacea ranged from 3.9–15.3 mg per serving; total ginsenosides in ginseng ranged from 5.3–18.2 mg per serving). Further, the amounts recommended for daily use also differed between brands, increasing the potential range of a consumer's daily dose. Echinacea and ginseng were the most variable, while St. John's wort and saw palmetto were the least variable. This study highlights some of the key issues in the botanical supplement market, including the importance of standardized manufacturing practices and reliable labeling information. In addition, health care providers should keep themselves informed regarding product quality in order to be able to appropriately advise patients utilizing both conventional and herbal medicines.http://dx.doi.org/10.1093/ecam/neh040
collection DOAJ
language English
format Article
sources DOAJ
author Robert Krochmal
Mary Hardy
Susan Bowerman
Qing-Yi Lu
H-J Wang
RM Elashoff
David Heber
spellingShingle Robert Krochmal
Mary Hardy
Susan Bowerman
Qing-Yi Lu
H-J Wang
RM Elashoff
David Heber
Phytochemical Assays of Commercial Botanical Dietary Supplements
Evidence-Based Complementary and Alternative Medicine
author_facet Robert Krochmal
Mary Hardy
Susan Bowerman
Qing-Yi Lu
H-J Wang
RM Elashoff
David Heber
author_sort Robert Krochmal
title Phytochemical Assays of Commercial Botanical Dietary Supplements
title_short Phytochemical Assays of Commercial Botanical Dietary Supplements
title_full Phytochemical Assays of Commercial Botanical Dietary Supplements
title_fullStr Phytochemical Assays of Commercial Botanical Dietary Supplements
title_full_unstemmed Phytochemical Assays of Commercial Botanical Dietary Supplements
title_sort phytochemical assays of commercial botanical dietary supplements
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2004-01-01
description The growing popularity of botanical dietary supplements (BDS) has been accompanied by concerns regarding the quality of commercial products. Health care providers, in particular, have an interest in knowing about product quality, in view of the issues related to herb-drug interactions and potential side effects. This study assessed whether commercial formulations of saw palmetto, kava kava, echinacea, ginseng and St. John's wort had consistent labeling and whether quantities of marker compounds agreed with the amounts stated on the label. We purchased six bottles each of two lots of supplements from nine manufacturers and analyzed the contents using established commercial methodologies at an independent laboratory. Product labels were found to vary in the information provided, such as serving recommendations and information about the herb itself (species, part of the plant, marker compound, etc.) With regard to marker compound content, little variability was observed between different lots of the same brand, while the content did vary widely between brands (e.g. total phenolic compounds in Echinacea ranged from 3.9–15.3 mg per serving; total ginsenosides in ginseng ranged from 5.3–18.2 mg per serving). Further, the amounts recommended for daily use also differed between brands, increasing the potential range of a consumer's daily dose. Echinacea and ginseng were the most variable, while St. John's wort and saw palmetto were the least variable. This study highlights some of the key issues in the botanical supplement market, including the importance of standardized manufacturing practices and reliable labeling information. In addition, health care providers should keep themselves informed regarding product quality in order to be able to appropriately advise patients utilizing both conventional and herbal medicines.
url http://dx.doi.org/10.1093/ecam/neh040
work_keys_str_mv AT robertkrochmal phytochemicalassaysofcommercialbotanicaldietarysupplements
AT maryhardy phytochemicalassaysofcommercialbotanicaldietarysupplements
AT susanbowerman phytochemicalassaysofcommercialbotanicaldietarysupplements
AT qingyilu phytochemicalassaysofcommercialbotanicaldietarysupplements
AT hjwang phytochemicalassaysofcommercialbotanicaldietarysupplements
AT rmelashoff phytochemicalassaysofcommercialbotanicaldietarysupplements
AT davidheber phytochemicalassaysofcommercialbotanicaldietarysupplements
_version_ 1725504676226400256